Clinical heterogeneity of α‐synuclein gene duplication in Parkinson's disease
Kenya Nishioka(Juntendo University), Nobutaka Hattori(RIKEN Center for Brain Science), Johji Inazawa(Shanghai Institute for Science of Science), Tatsushi Toda(Osaka University), Matthew J. Farrer(University of British Columbia), Toshiaki Kitami(Juntendo University), Ryu Kuroda(National Epilepsy Center), Issei Imoto(Tokushima University), Hisamasa Imai(Tokyo Rinkai Hospital), Yoshikuni Mizuno(Juntendo University), Andrew Singleton(Laboratory of Molecular Genetics), Kenichi Sato(Juntendo University), Hiroyuki Tomiyama(German Center for Neurodegenerative Diseases), Miho Murata(National Center of Neurology and Psychiatry), Hiroyo Yoshino(Juntendo University), Koichi Mizoguchi(National Epilepsy Center), Shin Hayashi(Tokyo Medical and Dental University)
Cited by 314
Related Papers
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
|Nature Genetics|2000|2k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy
|The Journal of Cell Biology|2010|1.9k